• Je něco špatně v tomto záznamu ?

Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation

R. Indra, P. Pompach, V. Martínek, P. Takácsová, K. Vavrová, Z. Heger, V. Adam, T. Eckschlager, K. Kopečková, VM. Arlt, M. Stiborová,

. 2019 ; 20 (14) : . [pub] 20190710

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19044670

Grantová podpora
18-10251S Grantová Agentura České Republiky

The metabolism of vandetanib, a tyrosine kinase inhibitor used for treatment of symptomatic/progressive medullary thyroid cancer, was studied using human hepatic microsomes, recombinant cytochromes P450 (CYPs) and flavin-containing monooxygenases (FMOs). The role of CYPs and FMOs in the microsomal metabolism of vandetanib to N-desmethylvandetanib and vandetanib-N-oxide was investigated by examining the effects of CYP/FMO inhibitors and by correlating CYP-/FMO-catalytic activities in each microsomal sample with the amounts of N-desmethylvandetanib/vandetanib-N-oxide formed by these samples. CYP3A4/FMO-activities significantly correlated with the formation of N-desmethylvandetanib/ vandetanib-N-oxide. Based on these studies, most of the vandetanib metabolism was attributed to N-desmethylvandetanib/vandetanib-N-oxide to CYP3A4/FMO3. Recombinant CYP3A4 was most efficient to form N-desmethylvandetanib, while FMO1/FMO3 generated N-oxide. Cytochrome b5 stimulated the CYP3A4-catalyzed formation of N-desmethylvandetanib, which is of great importance because CYP3A4 is not only most efficient in generating N-desmethylvandetanib, but also most significant due to its high expression in human liver. Molecular modeling indicated that binding of more than one molecule of vandetanib into the CYP3A4-active center can be responsible for the high efficiency of CYP3A4 N-demethylating vandetanib. Indeed, the CYP3A4-mediated reaction exhibits kinetics of positive cooperativity and this corresponded to the in silico model, where two vandetanib molecules were found in CYP3A4-active center.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044670
003      
CZ-PrNML
005      
20200113081138.0
007      
ta
008      
200109s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms20143392 $2 doi
035    __
$a (PubMed)31295928
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Indra, Radek $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, CZ-12843 Prague 2, Czech Republic.
245    10
$a Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation / $c R. Indra, P. Pompach, V. Martínek, P. Takácsová, K. Vavrová, Z. Heger, V. Adam, T. Eckschlager, K. Kopečková, VM. Arlt, M. Stiborová,
520    9_
$a The metabolism of vandetanib, a tyrosine kinase inhibitor used for treatment of symptomatic/progressive medullary thyroid cancer, was studied using human hepatic microsomes, recombinant cytochromes P450 (CYPs) and flavin-containing monooxygenases (FMOs). The role of CYPs and FMOs in the microsomal metabolism of vandetanib to N-desmethylvandetanib and vandetanib-N-oxide was investigated by examining the effects of CYP/FMO inhibitors and by correlating CYP-/FMO-catalytic activities in each microsomal sample with the amounts of N-desmethylvandetanib/vandetanib-N-oxide formed by these samples. CYP3A4/FMO-activities significantly correlated with the formation of N-desmethylvandetanib/ vandetanib-N-oxide. Based on these studies, most of the vandetanib metabolism was attributed to N-desmethylvandetanib/vandetanib-N-oxide to CYP3A4/FMO3. Recombinant CYP3A4 was most efficient to form N-desmethylvandetanib, while FMO1/FMO3 generated N-oxide. Cytochrome b5 stimulated the CYP3A4-catalyzed formation of N-desmethylvandetanib, which is of great importance because CYP3A4 is not only most efficient in generating N-desmethylvandetanib, but also most significant due to its high expression in human liver. Molecular modeling indicated that binding of more than one molecule of vandetanib into the CYP3A4-active center can be responsible for the high efficiency of CYP3A4 N-demethylating vandetanib. Indeed, the CYP3A4-mediated reaction exhibits kinetics of positive cooperativity and this corresponded to the in silico model, where two vandetanib molecules were found in CYP3A4-active center.
650    _2
$a zvířata $7 D000818
650    _2
$a antitumorózní látky $x chemie $x farmakologie $7 D000970
650    _2
$a cytochrom P-450 CYP3A $x chemie $x metabolismus $7 D051544
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a enzymy $x chemie $x metabolismus $7 D004798
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a jaterní mikrozomy $x metabolismus $7 D008862
650    _2
$a molekulární modely $7 D008958
650    _2
$a molekulární konformace $7 D008968
650    _2
$a molekulární struktura $7 D015394
650    12
$a oxidace-redukce $7 D010084
650    _2
$a piperidiny $x chemie $x farmakologie $7 D010880
650    _2
$a inhibitory proteinkinas $x chemie $x farmakologie $7 D047428
650    _2
$a chinazoliny $x chemie $x farmakologie $7 D011799
650    _2
$a králíci $7 D011817
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a rekombinantní proteiny $7 D011994
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pompach, Petr $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, CZ-12843 Prague 2, Czech Republic.
700    1_
$a Martínek, Václav $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, CZ-12843 Prague 2, Czech Republic.
700    1_
$a Takácsová, Paulína $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, CZ-12843 Prague 2, Czech Republic.
700    1_
$a Vavrová, Katarína $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, CZ-12843 Prague 2, Czech Republic.
700    1_
$a Heger, Zbyněk $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-61300 Brno, Czech Republic.
700    1_
$a Adam, Vojtěch $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-61300 Brno, Czech Republic.
700    1_
$a Eckschlager, Tomáš $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, V Uvalu 84/1, CZ-150 06 Prague 5, Czech Republic.
700    1_
$a Kopečková, Kateřina $u Department of Oncology, 2nd Medical Faculty, Charles University and University Hospital Motol, V Uvalu 84/1, CZ-150 06 Prague 5, Czech Republic.
700    1_
$a Arlt, Volker Manfred $u Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, 150 Stamford Street, London SE1 9NH, UK. NIHR Health Protection Research Unit in Health Impact of Environmental Hazards at King's College London in partnership with Public Health England and Imperial College London, 150 Stamford Street, London SE1 9NH, UK.
700    1_
$a Stiborová, Marie $u Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, CZ-12843 Prague 2, Czech Republic. stiborov@natur.cuni.cz.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 14 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31295928 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113081510 $b ABA008
999    __
$a ok $b bmc $g 1482939 $s 1083343
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 14 $e 20190710 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 18-10251S $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Možnosti archivace